Академический Документы
Профессиональный Документы
Культура Документы
Product Description
biosimilar adalimumab for the treatment of auto immune disorders
Biosimilar rituximab
Biosimilar rituximab (mAb targeting CD20)
Filgrastim (recombinant granulocyte-macrophage colony-stimulating factor, G-CSF)
Darbepoetin alfa (recombinant erythropoietin)
(pelfilgrastim)
darbepoetin alfa in collaboration with Cipla
Filgrastim (recombinant G-CSF)
PEGylated G-CSF
Recombinant human interferon alpha-2b
Recombinant erythropoietin
Rituximab
Recombinant interferon alpha-2b
Recombinant streptokinase
Recombinant erythropoietin
Recombinant erythropoietin
Recombinant G-CSF
Recombinant interferon alpha-2b
Interferon beta-la
Recombinant reteplase (tissue plasminogen activator)
Recombinant erythropoietin
Recombinant insulin
Recombinant human erythropoietin
Biosimilar nimotuzumab (humanized mAb targeting epidermal growth factor receptor)
Filgrastim, recombinant G-CSF
Recombinant streptokinase biosimilar
Recombinant human insulin
Itolizumab
Insulin glargine
Product Description
Rituximab
Biosimilar rituximab
Biosimilar rituximab (mAb targeting CD20)
Filgrastim (recombinant G-CSF)
Filgrastim (recombinant granulocyte-macrophage colony-stimulating factor, G-CSF)
(pelfilgrastim)
Recombinant G-CSF
Filgrastim, recombinant G-CSF
Recombinant erythropoietin
Darbepoetin alfa (recombinant erythropoietin)
Recombinant erythropoietin
Recombinant erythropoietin
Recombinant erythropoietin
Recombinant human erythropoietin
Recombinant human interferon alpha-2b
Recombinant interferon alpha-2b
Recombinant interferon alpha-2b
PEGylated G-CSF